TFE3 and renal cell carcinoma: Moreover, studies have found that surgical strategy, postoperative targeted drug therapy, and local lymph node invasion are important factors associated with progression in TFE3-RCC patients, and TKI plays an important role in prolonging the survival of patients; therefore, clinicians can consider applying TKI consolidation therapy to postoperative patients.